News

Video

KRAS in Pancreatic Cancer: Recent Updates in Biomarker and Drug Development

Related Videos
Shaji Kumar, MD
Kevin Kalinsky, MD, MS
Guru P. Sonpavde, MD
OncLive co-hosts Kristie L. Kahl and Andrew Svonavec highlight abstracts for medical oncologists to look out for at the upcoming ASH Annual Meeting in San Diego, with some additional tidbits to round out the main event.
Related Content
ReisMedia - stock.adobe.com
December 4th 2024

NICE Recommends Tebentafusp Reimbursement for HLA-A*02:01+ Uveal Melanoma

Burst CME™: Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Current Options and Emerging Approaches
December 3rd 2024

Burst CME™: Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Current Options and Emerging Approaches

Fellows of the American College of Surgeons | Image Credit: © Katsyarina - stock.adobe.com
December 4th 2024

Fox Chase Cancer Center’s Dr. Anthony M. Villano and Dr. Austin D. Williams Named Fellows of the American College of Surgeons

John Strickler, MD, professor, medicine, Division of Medical Oncology, associate director, Clinical Research – GI Oncology, co-leader, Precision Cancer Medicine and Investigational Therapeutics Program, Duke Cancer Institute
December 2nd 2024

Pancreatic Cancer Research Surfaces Treatment Developments and Challenges: With John Strickler, MD

Breast Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
December 4th 2024

Disitamab Vedotin Shows Early Efficacy in HER2-Expressing Breast Cancer With PAM Pathway Abnormalities

Lung Cancer | Image Credit: © catalin – stock.adobe.com
December 3rd 2024

FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan for EGFR+ NSCLC